BiotechTubeBiotechTube
Home/Click Therapeutics/Steven Lee
SL

Steven Lee

Director, Strategy

Click Therapeutics

Therapeutic Areas

PsychiatryNeurologyOncology

Click Therapeutics Pipeline

DrugIndicationPhase
CT-152 (Rejoyn™)Major Depressive Disorder (adjunct to antidepressant medication)Phase 3
CT-132Episodic MigrainePhase 3
CT-155Negative Symptoms of SchizophreniaPhase 3
Unnamed Breast Cancer ProgramBreast CancerPilot/Phase 2

Leadership Team at Click Therapeutics

DB
David Benshoof Klein
Founder & CEO
RS
Randall Stanicky
Chief Financial Officer
AS
Austin Speier
Chief Strategy Officer
View full Click Therapeutics profile